The Triptan Formulations
- 1 January 2003
- journal article
- review article
- Published by Springer Science and Business Media LLC in CNS Drugs
- Vol. 17 (6), 431-447
- https://doi.org/10.2165/00023210-200317060-00005
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Triptans in MigraineDrugs, 2000
- The Acute Treatment of Migraine with FrovatriptanPublished by S. Karger AG ,2000
- A Long-term Study to Maximise Migraine Relief with ZolmitriptanCurrent Medical Research and Opinion, 1999
- EletriptanCNS Drugs, 1999
- Crossover Comparison of Rizatriptan 5 mg and 10 mg Versus Sumatriptan 25 mg and 50 mg in MigraineHeadache: The Journal of Head and Face Pain, 1998
- Rizatriptan (MAXALT) for the Acute Treatment of Migraine and Migraine Recurrence. A Placebo‐Controlled, Outpatient StudyHeadache: The Journal of Head and Face Pain, 1998
- Naratriptan is Effective and Well Tolerated in the Acute Treatment of Migraine. Results of a Double‐Blind, Placebo‐Controlled, Parallel‐Group StudyHeadache: The Journal of Head and Face Pain, 1997
- Oral Sumatriptan: Effect of a Second Dose, and Incidence and Treatment of Headache RecurrencesCephalalgia, 1994
- Intranasal sumatriptan for the acute treatment of migraineZeitschrift für Neurologie, 1994
- Sumatriptan An Oral Dose-Defining StudyEuropean Neurology, 1991